Does HLA-C genotype affect antigen presentation to CD8+ T cells and NK-cell regulation, influencing viral control?

The HLA-C genotype plays a fundamental role in coordinating both the innate and adaptive immune responses. By modulating the expression levels and structural stability of HLA-C molecules, genetic variations directly influence the efficiency of antigen presentation to CD8+ T cells and the functional "licensing" of natural killer (NK) cells through interactions with killer-cell immunoglobulin-like receptors (KIRs).

Clinical and effectiveness evidence

HLA-C genetic variation is a major determinant of viral load set-points and disease progression, particularly in chronic infections like HIV-1 and Hepatitis C.

• HIV Control: Individuals carrying alleles associated with high HLA-C expression (such as the -35C variant or rs9264942 CC genotype) consistently exhibit lower viral loads and slower progression to AIDS. Large-scale genome-wide association studies (GWAS) have identified these variants as primary predictors of viral control.
• Hepatitis C (HCV): HLA-C1 and C2 group classifications, combined with their respective KIR ligands, significantly influence the likelihood of spontaneous clearance versus chronic infection.
• Protective Alleles: The presence of high-expression alleles increases the immune pressure on viruses, often forcing the virus to develop specific "escape mutations" to avoid detection, which can sometimes reduce the virus's overall fitness.

Mechanistic explanations

The influence of HLA-C on immune regulation operates through two distinct molecular pathways:

• CD8+ T-Cell Presentation: HLA-C genotypes determine the density of MHC-I molecules on the cell surface. Polymorphisms in the peptide-binding groove (e.g., positions 97 and 21) affect which viral fragments are presented. High-expression alleles ensure a higher density of these complexes, facilitating more effective recognition and destruction of infected cells by cytotoxic T lymphocytes.
• NK-Cell Regulation (KIR Interaction): HLA-C molecules serve as the primary ligands for inhibitory KIRs (KIR2DL1/2/3). The interaction between HLA-C and these receptors is essential for NK cell "education" or "licensing." Paradoxically, stronger inhibitory signals during NK cell development result in more functionally potent NK cells that are better equipped to respond to "missing-self" signals when viruses attempt to downregulate MHC molecules to hide from T cells.

Genetic considerations

Specific SNPs, such as rs9264942, serve as critical regulators of these processes:

• rs9264942 C vs. T: The 'C' allele disrupts a microRNA (miR-519a) binding site that would otherwise degrade HLA-C mRNA. Consequently, the 'C' allele leads to higher protein expression.
• Heterozygosity (CT): Individuals with the CT genotype generally exhibit intermediate HLA-C expression levels. While they possess better viral control than those with the TT genotype, they may face a moderate increase in risk for reduced immune control compared to CC homozygotes.

Bottom line

The HLA-C genotype is a critical regulator of viral immunity, exerting its effects by increasing the visibility of infected cells to CD8+ T cells and optimizing the functional reactivity of NK cells. High-expression genotypes are strongly associated with superior control of chronic viral infections.